A phase Ib clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and avelumab (AVE) plus intravenous low-dose nivolumab (NIVO) in patients with advanced solid tumors.

Onderzoeksoutput: Meeting abstract (Book)

Originele taal-2English
TitelJournal of Clinical Oncology
UitgeverijAmerican Society of Clinical Oncology
StatusPublished - mei 2019
EvenementASCO Annual Meeting 2019 - Chicago, Illinois, USA, Chicago, United States
Duur: 31 mei 20194 jun 2019


ConferenceASCO Annual Meeting 2019
LandUnited States

Citeer dit